|
US6921762B2
(en)
|
2001-11-16 |
2005-07-26 |
Amgen Inc. |
Substituted indolizine-like compounds and methods of use
|
|
WO2010021381A1
(ja)
|
2008-08-22 |
2010-02-25 |
武田薬品工業株式会社 |
縮合複素環誘導体およびその用途
|
|
UA110112C2
(uk)
|
2010-05-07 |
2015-11-25 |
Глаксосмітклайн Ллс |
Індоли
|
|
US8846935B2
(en)
|
2010-05-07 |
2014-09-30 |
Glaxosmithkline Llc |
Indazoles
|
|
US9175331B2
(en)
|
2010-09-10 |
2015-11-03 |
Epizyme, Inc. |
Inhibitors of human EZH2, and methods of use thereof
|
|
US20130310379A1
(en)
|
2010-11-19 |
2013-11-21 |
Constellation Pharmaceuticals |
Modulators of methyl modifying enzymes, compositions and uses thereof
|
|
CA2819620A1
(en)
|
2010-12-03 |
2012-06-21 |
Epizyme, Inc. |
Modulators of histone methyltransferase, and methods of use thereof
|
|
ES2951688T3
(es)
|
2011-02-28 |
2023-10-24 |
Epizyme Inc |
Compuestos de heteroarilo biciclico fusionados en 6,5 sustituidos
|
|
JO3363B1
(ar)
|
2011-04-13 |
2019-03-13 |
Epizyme Inc |
مركبات بنزين مستبدلة بأريل أو أريل غير متجانس
|
|
TWI598336B
(zh)
|
2011-04-13 |
2017-09-11 |
雅酶股份有限公司 |
經取代之苯化合物
|
|
CA2834164A1
(en)
|
2011-05-10 |
2012-11-15 |
Gilead Sciences, Inc. |
Fused benzoxazinones as ion channel modulators
|
|
CA2850570A1
(en)
|
2011-09-30 |
2013-04-04 |
Glaxosmithkline Llc |
Methods of treating cancer
|
|
WO2013063417A1
(en)
|
2011-10-27 |
2013-05-02 |
Memorial Sloan-Kettering Cancer Center |
Methyltransferase inhibitors for treating cancer
|
|
EP2780014A4
(en)
|
2011-11-18 |
2015-07-01 |
Constellation Pharmaceuticals Inc |
MODULATORS OF METHYL MODIFYING ENZYMES, COMPOSITIONS AND USES THEREOF
|
|
EP2780013A4
(en)
|
2011-11-18 |
2015-07-01 |
Constellation Pharmaceuticals Inc |
MODULATORS OF METHYL MODIFYING ENZYMES, COMPOSITIONS AND USES THEREOF
|
|
NZ628762A
(en)
|
2012-02-10 |
2016-07-29 |
Constellation Pharmaceuticals Inc |
Modulators of methyl modifying enzymes, compositions and uses thereof
|
|
SG10201912111TA
(en)
|
2012-04-13 |
2020-02-27 |
Epizyme Inc |
Combination therapy for treating cancer
|
|
WO2013173441A2
(en)
|
2012-05-16 |
2013-11-21 |
Glaxosmithkline Llc |
Enhancer of zeste homolog 2 inhibitors
|
|
US9105490B2
(en)
|
2012-09-27 |
2015-08-11 |
Taiwan Semiconductor Manufacturing Company, Ltd. |
Contact structure of semiconductor device
|
|
JP6254169B2
(ja)
|
2012-09-28 |
2017-12-27 |
ファイザー・インク |
ベンズアミドおよびヘテロベンズアミド化合物
|
|
MX2015004721A
(es)
|
2012-10-15 |
2016-01-25 |
Epizyme Inc |
Compuestos de benceno sustituidos.
|
|
KR20230156450A
(ko)
|
2012-10-15 |
2023-11-14 |
에피자임, 인코포레이티드 |
암을 치료하는 방법
|
|
EP2931707A4
(en)
|
2012-12-13 |
2016-07-20 |
Glaxosmithkline Llc |
AMPLIFIER OF ZEST HOMOLOG 2 INHIBITORS
|
|
AU2013361060B2
(en)
|
2012-12-21 |
2018-04-19 |
Epizyme, Inc. |
1,4-pyridone compounds
|
|
CA2894222A1
(en)
|
2012-12-21 |
2014-06-26 |
Epizyme, Inc. |
1,4-pyridone bicyclic heteroaryl compounds
|
|
UA111305C2
(uk)
|
2012-12-21 |
2016-04-11 |
Пфайзер Інк. |
Конденсовані лактами арилу та гетероарилу
|
|
SI2953941T1
(sl)
|
2013-02-11 |
2017-08-31 |
Constellation Pharmaceuticals, Inc. |
Modulatorji metil-modificirajočih encimov, sestavki in uporabe le-teh
|
|
US9045477B2
(en)
|
2013-03-15 |
2015-06-02 |
Epizyme, Inc. |
Substituted 6,5-fused bicyclic heteroaryl compounds
|
|
WO2014151142A1
(en)
|
2013-03-15 |
2014-09-25 |
Constellation Pharmaceuticals, Inc. |
Modulators of methyl modifying enzymes, compositions and uses thereof
|
|
US9776996B2
(en)
|
2013-03-15 |
2017-10-03 |
Epizyme, Inc. |
Substituted 6,5-fused bicyclic heteroaryl compounds
|
|
US9243001B2
(en)
|
2013-03-15 |
2016-01-26 |
Epizyme, Inc. |
Substituted benzene compounds
|
|
CA2903572A1
(en)
|
2013-03-15 |
2014-10-23 |
Epizyme, Inc. |
Substituted benzene compounds
|
|
EP2991980B1
(en)
|
2013-04-30 |
2019-01-02 |
Glaxosmithkline Intellectual Property (No. 2) Limited |
Enhancer of zeste homolog 2 inhibitors
|
|
BR112015030515A2
(pt)
|
2013-06-06 |
2017-07-25 |
Glaxosmithkline Ip No 2 Ltd |
intensificadores de inibidores de homólogo 2 de zeste
|
|
KR20160030221A
(ko)
|
2013-07-10 |
2016-03-16 |
글락소스미스클라인 인털렉츄얼 프로퍼티 (넘버 2) 리미티드 |
제스트 인핸서 상동체 2 억제제
|
|
US10150764B2
(en)
|
2013-07-19 |
2018-12-11 |
Epizyme, Inc. |
Substituted benzene compounds
|
|
WO2015010078A2
(en)
|
2013-07-19 |
2015-01-22 |
Epizyme, Inc. |
Substituted 6,5-fused bicyclic heteroaryl compounds
|
|
EP3033334A1
(en)
|
2013-08-15 |
2016-06-22 |
Constellation Pharmaceuticals, Inc. |
Indole derivatives as modulators of methyl modifying enzymes, compositions and uses thereof
|
|
US9738630B2
(en)
|
2013-11-19 |
2017-08-22 |
Bristol-Myers Squibb Company |
Inhibitors of lysine methyl transferase
|
|
WO2015077194A1
(en)
|
2013-11-22 |
2015-05-28 |
Bristol-Myers Squibb Company |
Inhibitors of lysine methyl transferase
|
|
WO2015128837A1
(en)
|
2014-02-26 |
2015-09-03 |
Glaxosmithkline Intellectual Property (No.2) Limited |
Methods of treating cancer patients responding to ezh2 inhibitor gsk126
|
|
CN106255693A
(zh)
|
2014-03-07 |
2016-12-21 |
葛兰素史密斯克莱知识产权（第2 号）有限公司 |
Zeste增强子同源物2的抑制剂
|
|
SI3121175T1
(sl)
|
2014-03-17 |
2020-07-31 |
Daiichi Sankyo Company, Limited |
Derivati 1,3-benzodioksola kot EZH1 in/ali EZH2 inhibitorji
|
|
WO2015193768A1
(en)
|
2014-06-17 |
2015-12-23 |
Pfizer Inc. |
Aryl fused lactams as ezh2 modulators
|
|
EP3157915B1
(en)
|
2014-06-17 |
2019-02-27 |
Pfizer Inc |
Substituted dihydroisoquinolinone compounds
|
|
CN107148419A
(zh)
|
2014-10-28 |
2017-09-08 |
葛兰素史密斯克莱知识产权（第2 号）有限公司 |
Zeste增强子同源物2抑制剂
|
|
EP3215160A4
(en)
|
2014-11-06 |
2018-08-08 |
Dana-Farber Cancer Institute, Inc. |
Use of compositions modulating chromatin structure for graft versus host disease (gvhd)
|
|
EP3885343A1
(en)
|
2014-11-06 |
2021-09-29 |
Dana-Farber Cancer Institute, Inc. |
Indole compounds as ezh2 inhibitors and uses thereof
|
|
AR102767A1
(es)
|
2014-12-05 |
2017-03-22 |
Lilly Co Eli |
Inhibidores de ezh2
|
|
WO2016102493A1
(en)
|
2014-12-22 |
2016-06-30 |
Bayer Pharma Aktiengesellschaft |
Imidazopyridine ezh2 inhibitors
|
|
CA2969090C
(en)
|
2014-12-23 |
2023-05-02 |
Novartis Ag |
Triazolopyrimidine compounds and uses thereof
|
|
IL236420A
(en)
|
2014-12-23 |
2016-06-30 |
Ron Schneider |
Methods and systems for producing an enlarged 3D image
|
|
WO2016123387A1
(en)
|
2015-01-30 |
2016-08-04 |
Genentech, Inc. |
Therapeutic compounds and uses thereof
|
|
WO2016130396A1
(en)
|
2015-02-13 |
2016-08-18 |
Constellation Pharmaceuticals, Inc. |
Modulators of methyl modifying enzymes, compositions and uses thereof
|
|
TW201718598A
(zh)
|
2015-08-27 |
2017-06-01 |
美國禮來大藥廠 |
Ｅｚｈ２抑制劑
|
|
RS59763B1
(sr)
|
2015-11-19 |
2020-02-28 |
Jiangsu Hengrui Medicine Co |
Derivati benzofurana, postupci njihove pripreme i njihova upotreba u medicini
|
|
CN108697716A
(zh)
|
2015-12-07 |
2018-10-23 |
Epizyme股份有限公司 |
Ezh2抑制剂及其使用方法
|
|
WO2017174023A1
(zh)
|
2016-04-08 |
2017-10-12 |
南京明德新药研发股份有限公司 |
作为ezh2抑制剂的联苯化合物
|
|
AU2017252460B2
(en)
|
2016-04-22 |
2021-11-18 |
Dana-Farber Cancer Institute, Inc. |
EZH2 inhibitors and uses thereof
|
|
CA3023157A1
(en)
|
2016-05-05 |
2017-11-09 |
Glaxosmithkline Intellectual Property (No.2) Limited |
Enhancer of zeste homolog 2 inhibitors
|
|
US9957274B2
(en)
|
2016-05-06 |
2018-05-01 |
Abbvie Inc. |
Indane inhibitors of EED and methods of their use
|
|
CA3025933A1
(en)
|
2016-06-01 |
2017-12-07 |
Epizyme, Inc. |
Use of ezh2 inhibitors for treating cancer
|
|
WO2017218953A1
(en)
|
2016-06-17 |
2017-12-21 |
Epizyme, Inc. |
Ezh2 inhibitors for treating cancer
|
|
WO2017221100A1
(en)
*
|
2016-06-20 |
2017-12-28 |
Novartis Ag |
Imidazopyrimidine compounds useful for the treatment of cancer
|
|
WO2017221092A1
(en)
|
2016-06-20 |
2017-12-28 |
Novartis Ag |
Triazolopyridine compounds and uses thereof
|
|
JP7042812B2
(ja)
|
2016-06-20 |
2022-03-28 |
ノバルティス アーゲー |
トリアゾロピリミジン化合物の結晶形態
|
|
US10266542B2
(en)
|
2017-03-15 |
2019-04-23 |
Mirati Therapeutics, Inc. |
EZH2 inhibitors
|
|
WO2019062435A1
(zh)
|
2017-09-28 |
2019-04-04 |
中国科学院上海药物研究所 |
三氮唑并嘧啶、三氮唑并吡啶化合物及其组合物用于治疗prc2介导的疾病
|
|
CN109942556A
(zh)
|
2017-12-21 |
2019-06-28 |
上海青煜医药科技有限公司 |
嘧啶酮化合物及其应用
|
|
DK3746446T3
(da)
|
2018-01-31 |
2022-06-27 |
Mirati Therapeutics Inc |
PRC2-inhibitorer
|
|
CN110156787B
(zh)
|
2018-02-13 |
2021-11-02 |
中国科学院上海药物研究所 |
一种三氮唑并嘧啶衍生化合物、包含其的药物组合物及其用途
|
|
CN110563722A
(zh)
|
2018-06-06 |
2019-12-13 |
上海青煜医药科技有限公司 |
吡啶或哒嗪并环化合物及其应用
|
|
US12421228B2
(en)
|
2019-04-22 |
2025-09-23 |
Mirati Therapeutics, Inc. |
Naphthyridine derivatives as PRC2 inhibitors
|
|
US12252493B2
(en)
|
2019-06-05 |
2025-03-18 |
Mirati Therapeutics, Inc. |
Imidazo[1,2-c]pyrimidine derivatives as PRC2 inhibitors for treating cancer
|